<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmexec.com/view/your-questions-answered-glp1-deals-fda-approvals-manufacturing-buildout</loc>
      <lastmod>2026-11-18T20:00:30.215Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T20:00:30.215Z</news:publication_date>
        <news:title><![CDATA[Your Questions Answered: GLP-1 Deals, FDA Approvals, and Manufacturing Buildout]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/daily-white-house-withdraws-fda-nomination-dr-heidi-overton-</loc>
      <lastmod>2026-11-18T19:48:36.491Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T19:48:36.491Z</news:publication_date>
        <news:title><![CDATA[Pharmaceutical Executive Daily: White House Withdraws FDA Nomination For Dr. Heidi Overton’s]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/white-house-withdraws-dr-heidi-overton-nomination-fda-commissioner-report</loc>
      <lastmod>2026-11-18T15:28:24.565Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T15:28:24.565Z</news:publication_date>
        <news:title><![CDATA[White House Withdraws Dr. Heidi Overton’s Nomination as FDA Commissioner: Report]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/pfizer-verismo-licensing-deals-car-t-manufacturing-in-vivo</loc>
      <lastmod>2026-11-18T14:41:34.832Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T14:41:34.832Z</news:publication_date>
        <news:title><![CDATA[Pfizer, Verismo Strike Licensing Deals to Push CAR T Manufacturing In Vivo]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/workload-balance-between-humans-agentic-models</loc>
      <lastmod>2026-11-18T11:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T11:00:00Z</news:publication_date>
        <news:title><![CDATA[The Workload Balance in Pharma Between Humans and Agentic Models]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/-daily-fda-approves-cosentyx-wilserdly</loc>
      <lastmod>2026-11-17T20:12:31.812Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:12:31.812Z</news:publication_date>
        <news:title><![CDATA[Pharmaceutical Executive Daily: FDA Approves Cosentyx and Wilserdly]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/gilead-signs-royalty-free-licensing-deals-broaden-access-obeldesivir</loc>
      <lastmod>2026-11-17T14:56:51.962Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T14:56:51.962Z</news:publication_date>
        <news:title><![CDATA[Gilead Signs Royalty-Free Licensing Deals to Broaden Access to Obeldesivir ]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/fda-approves-cosentyx-polymyalgia-rheumatica-wilserdly-er-positive-esr1-mutated-advanced-breast-cancer</loc>
      <lastmod>2026-11-17T14:27:53.162Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T14:27:53.162Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Cosentyx for Polymyalgia Rheumatica, Wilserdly for ER-Positive ESR1-Mutated Advanced Breast Cancer ]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmexec.com/view/workflows-impacted-agentic-models-beyond-productivity-gains</loc>
      <lastmod>2026-11-17T11:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>PharmExec</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T11:00:00Z</news:publication_date>
        <news:title><![CDATA[How Pharma Workflows Are Impacted by Agentic Models Beyond Productivity Gains]]></news:title>
      </news:news>
	</url></urlset>